Pharmacokinetic, biodistribution, safety and efficacy studies of borophenylalanine (BPA) in BNCT in hepatocellular carcinoma cells and tumor-bearing mouse model

Pharmacokinetic, biodistribution, safety and efficacy studies of borophenylalanine (BPA) in BNCT in hepatocellular carcinoma cells and tumor-bearing mouse model

Abstract Boron neutron capture therapy (BNCT), using boronophenylalanine (BPA) as the main boron carrier, is a dual-targeted particle radiotherapy at the cellular level. Although BPA shows clinical promise in liver cancer, there is relatively little basic research on its effect on hepatocellular car...

Full description

Saved in:
Bibliographic Details
Main Authors: Tanglong Zhang, Pengcheng Zhang, Huanyu Zhang, Zhuoya Zhang, Xiaodong Jin, Ting Zhao, Juntao Ran
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Boron neutron capture therapy
Distribution of drugs
Pharmacokinetic
BPA
Online Access:https://doi.org/10.1038/s41598-025-14885-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-14885-1

Similar Items